- Home
- MTNB
as 11-25-2024 9:46am EST
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | BEDMINSTER |
| Market Cap: | 16.1M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 578.7K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.52 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.50 - $21.50 | Next Earning Date: | 11-13-2024 |
| Revenue: | N/A | Revenue Growth: | -65.62% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Matinas Biopharma Holdings Inc. News
MTNB Breaking Stock News: Dive into MTNB Ticker-Specific Updates for Smart Investing
MT Newswires
25 days ago
Top Midday Decliners
GlobeNewswire
25 days ago
Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction
GuruFocus.com
a month ago
Highbridge Capital Management's Strategic Acquisition in Matinas BioPharma
TipRanks
3 months ago
Upcoming Stock Splits This Week (September 2 to September 6) – Stay Invested
GlobeNewswire
3 months ago
Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire
4 months ago
Matinas BioPharma to Webcast Conference Call to Discuss Second Quarter 2024 Financial Results and Provide a Business Update on August 14, 2024
GlobeNewswire
5 months ago
Matinas BioPharma Reports Successful Treatment of Patient with Limb-Threatening Mucor Infection in its Oral MAT2203 Compassionate/Expanded Use Access Program
GlobeNewswire
5 months ago
Matinas BioPharma’s Oral MAT2203 to Be Featured in Fireside Chat Hosted by A.G.P. with Antifungal Expert Dr. David S. Perlin
Compare MTNB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MTNB Matinas Biopharma Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.